mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
2e-05 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.0009 |